Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

NCT02517554 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT02517554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02517554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
November 30, 2019
Enrollment
120 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, ovarian cancer